logo-loader
viewEden Research PLC

Eden Research helping to transform crop science

The firm's Sustaine encapsulation technology is free from plastics, is derived from a natural source, and is suitable for use with both sustainable biopesticides and conventional synthetic pesticides

Eden Research plc -

Crop science’s focus on protecting plants from seed to harvest is changing as it faces environmental and regulatory challenges.

Key among them is the issue of polymer-based coatings used to preserve and protect seeds that are adding to the microplastics problem.

Two years ago, the European Union initiated restrictions on the use of these tiny pollutants in cosmetics and most experts believe the agri-sector has no more than five years before it is subject to similar strictures.

And while this appears to give the industry some leeway, one should remember that once a replacement for traditional encapsulation technology is found, the whole process of registration and field trials kicks in, adding at least another two years to the process.

Bearing this in mind, it shouldn’t be a surprise to learn that the world’s largest chemicals businesses are casting around for ready-made solutions.

Deal with American agrisciences giant

It also explains why Corteva Agrisciences, the American giant valued at US$21bn, has teamed up with a UK small-cap that appears to have cracked the microplastics problem.

Eden Research plc’s (LON:EDEN) Sustaine encapsulation technology is free from plastics, is derived from a natural source, and is suitable for use with both sustainable biopesticides and conventional synthetic pesticides.  

Indeed, it is this technology that has enabled the commercialisation of Eden’s own biopesticides which are used to protect grapevines and various other crops.

Last Wednesday (Jan 8) Eden said it had signed a one-year exclusive evaluation agreement with Corteva – the former’s its first foray into the seed market.

While the exact details of the evaluation haven’t been released, Eden chief executive Sean Smith confirmed Sustaine would be used on a “significant crop”.

Success would provide a big commercial kicker. That’s because Corteva, a combine of the agri-assets of Dow Chemicals and DuPont, would then assume exclusive distribution rights in the EU, Russia, Ukraine and Turkey. 

Others interested 

According to CEO Smith, there are other, more big wheels from the world of plant science talking to Eden about its terpene-based products.

It already has two products on the market, Mevalone (a bio-fungicide) and Cedroz, which protects against soil-based pests called nematodes.

Its existing partnerships with industry big hitters such as, Eastman, Sipcam Oxon and SumiAgro have opened the doors to deals in Mexico, Portugal, Italy and the Benelux countries to name a few.

But, as the company’s broker Cenkos pointed out, the Corteva tie-up brings with it a certain cachet.

“We see this agreement, following positive field trials, as a strong endorsement of Eden’s Sustaine technology,” said analyst Chris Donnellan.

Quick facts: Eden Research PLC

Price: 7.75 GBX

AIM:EDEN
Market: AIM
Market Cap: £29.48 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research PLC named herein, including the promotion by the Company of Eden Research PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Eden Research PLC keen to add US to list of markets for natural fungicide

Sean Smith, chief executive of Eden Research PLC, explains the technology behind its range of naturally-derived pesticides and why winegrowers in France, Spain and Italy are giving rave reviews to Mevalone, its grape fungicide. Work is already underway to get approval in the US as...

on 22/3/18

3 min read